Nasal Foralumab Shows Positive Results in Alzheimer’s Disease Study

The Journal of Clinical Nuclear Medicine has published results from a study of Tiziana Life Sciences’ nasal Foralumab. The study tested the drug in patients with moderate Alzheimer’s disease. Researchers gave one patient daily doses of nasal Foralumab for 13 weeks. They followed this with a 13-week treatment-free period. The patient showed reduced brain inflammation […]
Nasal Sprays: A New Hope in Dementia Treatment

Imagine this: you’re sitting at the kitchen table, sipping your morning coffee, when you come across an article about a new nasal spray that might help treat dementia. It sounds like something out of science fiction, doesn’t it? But this isn’t a plot from a futuristic novel; it’s happening right now. Researchers are exploring innovative […]
